United States
Print page content Print
Increase text size Decrease text size
Text Size

SIMPLICEF®

(cefpodoxime proxetil)

SIMPLICEF has a long half-life allowing once-daily dosing, which can result in greater compliance and better clinical outcomes

SIMPLICEF is indicated for dogs with skin infections (wounds and abscesses) caused by susceptible strains of Staphylococcus intermedius, Staphylococcus aureus, Streptococcus canis (Group G, β-hemolytic), Escherchia coli, Pasteurella multocida, and Proteus mirabilis.

Its long half-life allows for once-daily dosing, which may result in increased compliance and better clinical outcomes.

Supplied:
SIMPLICEF tablets are available in the following strengths (cefpodoxime equivalent), colors, and sizes:
100 mg (reddish-orange, elliptical, scored, debossed with 5228) in 100 ct and 250 ct bottles.
200 mg (light orange, round rectangle, scored, debossed with 5229) in 100 ct and 250 ct bottles.

Expand All
    • Ideal pharmacokinetic profile for an oral time-dependent cepholosporin.
    • Long half-life allows for once-daily dosing, which can result in increased compliance and better clinical outcomes.
    • Effective in treating skin infections (wounds and abscesses) in dogs.
    • Many large dogs can be treated with just 1 tablet.
    • Tablets are film coated, odorless and scored for easier administration.
    • Tablets can be given with or without food.


  • Please refer to the full Prescribing Information for more dosage and administration information.



     


IMPORTANT SAFETY INFORMATION:
People with known hypersensitivity to penicillin or cephalosporins should avoid exposure to SIMPLICEF. Do not use in dogs with known allergy to penicillins or cephalosporins.

See full Prescribing Information, attached.